Flagship raises $3.6B for biotech investing

Flagship raises $3.6B for biotech investing

Dive Brief: Flagship Pioneering said Wednesday that it’s added another $3.6 billion to its capital base, bringing the total raised since 2021 to $6.4 billion. The Cambridge, Massachusetts-based company said…
Novo’s once-weekly insulin rejected by FDA

Novo’s once-weekly insulin rejected by FDA

Dive Brief: The Food and Drug Administration rejected Novo Nordisk’s application to sell a once-weekly insulin treatment called icodec, sending the Danish drugmaker a series of requests related to manufacturing…